Loading...
Market
Outcome of FTC lawsuit against CVS, Cigna, UnitedHealth over insulin price inflation by end of 2024?
2
Resolution / Starting Odds
FTC wins • 25%
FTC loses • 25%
Settlement reached • 25%
Case dismissed • 25%
Official FTC announcements, court records
Story
FTC Sues PBMs CVS, Cigna, UnitedHealth Over Inflated Insulin Prices on Friday
Sep 20, 2024, 04:04 PM
The U.S. Federal Trade Commission (FTC) has filed a lawsuit against the three largest pharmacy benefit managers (PBMs) - CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx. The FTC alleges that these PBMs engaged in illegal rebate programs that artificially inflated the cost of insulin, thereby increasing profits at the expense of patients. The lawsuit, filed on Friday, does not name insulin drugmakers Eli Lilly, Novo Nordisk, and Sanofi, but the FTC reserves the right to sue these companies later.
View original story
Similar markets
FTC wins • 25%
FTC loses • 25%
Settlement reached • 25%
Case dismissed • 25%
Settlement reached • 25%
FTC wins the case • 25%
PBMs win the case • 25%
Case is ongoing • 25%
FTC wins the lawsuit • 25%
FTC loses the lawsuit • 25%
Settlement reached • 25%
Lawsuit ongoing • 25%
FTC wins • 25%
FTC loses • 25%
Settled out of court • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
FTC wins all lawsuits • 25%
FTC wins some lawsuits • 25%
FTC loses all lawsuits • 25%
Settlements reached • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%